✦ LIBER ✦

POS5 THE COST-EFFECTIVENESS OF IBANDRONATE IN THE TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS IN THE US

✍ Scribed by SR Earnshaw; CN Graham; MM Amonkar; CE Barr

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

USE OF IBANDRONATE IN THE TREATMENT OF P

✍ S. Yureneva; V. Smetnik; S. Kuznetzov; N. Bilak 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Cost-effectiveness of denosumab in the t

✍ Chau, D.; Becker, D. L.; Coombes, M. E.; Ioannidis, G.; Adachi, J. D.; Goeree, R 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 282 KB

POS6 ECONOMIC ANALYSIS: IBANDRONATE (BON

✍ W Cowell; A Koay; M Hunjan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Intravenous injections of ibandronate (I

✍ D. Thiébaud; H. Kriegbaum; H. Huss; C. Christiansen; P. Burckhardt 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 158 KB

Cost-effectiveness of Denosumab for the

✍ B. Jönsson; O. Ström; J. A. Eisman; A. Papaioannou; E. S. Siris; A. Tosteson; J. 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 336 KB

PMS44 Cost-Effectiveness of Denosumab in

✍ A. Davies; J. Compston; S. Ferguson; E. McClosky; A. Shearer; A. Taylor 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB